Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.
Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL. Vieira CS, et al. Among authors: fraser is. Contraception. 2019 Dec;100(6):438-444. doi: 10.1016/j.contraception.2019.07.145. Epub 2019 Aug 6. Contraception. 2019. PMID: 31398307 Free PMC article. Clinical Trial.
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.
Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, Thomas M, Barnhart KT, Creasy G, Sussman H, Alami M, Burke AE, Weisberg E, Fraser I, Miranda MJ, Gilliam M, Liu J, Carr BR, Plagianos M, Roberts K, Blithe D. Gemzell-Danielsson K, et al. Contraception. 2019 Jun;99(6):323-328. doi: 10.1016/j.contraception.2019.02.001. Epub 2019 Mar 1. Contraception. 2019. PMID: 30831102 Free PMC article. Clinical Trial.
Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Sivin I, Tsong YY, Fraser IS. Weisberg E, et al. Among authors: fraser is. Contraception. 2005 Jul;72(1):46-52. doi: 10.1016/j.contraception.2004.12.014. Contraception. 2005. PMID: 15964292 Clinical Trial.
Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.
Jensen J, Mansour D, Lukkari-Lax E, Inki P, Burock K, Fraser IS. Jensen J, et al. Among authors: fraser is. Contraception. 2013 Jan;87(1):107-12. doi: 10.1016/j.contraception.2012.08.022. Epub 2012 Oct 4. Contraception. 2013. PMID: 23040140 Clinical Trial.
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Fraser IS, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J. Fraser IS, et al. Eur J Contracept Reprod Health Care. 2011 Aug;16(4):258-69. doi: 10.3109/13625187.2011.591456. Eur J Contracept Reprod Health Care. 2011. PMID: 21774563 Free PMC article.
Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Fraser IS, Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Tsong YY, Sivin I. Fraser IS, et al. Contraception. 2005 Jul;72(1):40-5. doi: 10.1016/j.contraception.2004.12.015. Contraception. 2005. PMID: 15964291 Clinical Trial.
377 results